Differential regulation of collapsin response mediator protein 2 (CRMP2) phosphorylation by GSK3ß and CDK5 following traumatic brain injury

Frontiers in Cellular Neuroscience

Volumn 8, Issue MAY, 2014, Pages

  Wilson, Sarah M ^a   Yeon, Seul Ki ^b   Yang, Xiao Fang ^c   Park, Ki Duk ^b   Khanna, Rajesh ^a,c  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Korea Institute of Science and Technology   (South Korea)

^c UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

(S) Lacosamide; CDK5; CRMP2; Epileptogenesis; GSK3 ; Mossy fiber sprouting; Phosphorylation; TIMM staining

Indexed keywords

EID: 84901604890     PISSN: 16625102     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncel.2014.00135     Document Type: Article

References (76)

1. Agrawal, A., Timothy, J., Pandit, L., and Manju, M. (2006). Post-traumatic epilepsy: an overview. Clin. Neurol. Neurosurg. 108, 433-439. doi: 10.1016/j.clineuro.2005.09.001
2. Alessi, D. R., Andjelkovic, M., Caudwell, B., Cron, P., Morrice, N., Cohen, P., et al. (1996). Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J. 15, 6541-6551.
3. Andersen, P., Bliss, T. V., Lomo, T., Olsen, L. I., and Skrede, K. K. (1969). Lamellar organization of hippocampal excitatory pathways. Acta Physiol. Scand. 76, 4a-5a.
4. Andurkar, S. V., Stables, J. P., and Kohn, H. (1999). The anticonvulsant activities of N-benzyl 3-methoxypropionamides. Bioorg. Med. Chem. 7, 2381-2389. doi: 10.1016/S0968-0896(99)00186-8
5. Arimura, N., Inagaki, N., Chihara, K., Menager, C., Nakamura, N., Amano, M., et al. (2000). Phosphorylation of collapsin response mediator protein-2 by Rho-kinase. Evidence for two separate signaling pathways for growth cone collapse. J. Biol. Chem. 275, 23973-23980. doi: 10.1074/jbc.M001032200
6. Arimura, N., Menager, C., Kawano, Y., Yoshimura, T., Kawabata, S., Hattori, A., et al. (2005). Phosphorylation by Rho kinase regulates CRMP-2 activity in growth cones. Mol. Cell Biol. 25, 9973-9984. doi: 10.1128/MCB.25.22.9973-9984.2005
7. Beyreuther, B. K., Freitag, J., Heers, C., Krebsfanger, N., Scharfenecker, U., and Stohr, T. (2007). Lacosamide: a review of preclinical properties. CNS Drug Rev. 13, 21-42. doi: 10.1111/j.1527-3458.2007.00001.x
8. Bhave, S. V., Ghoda, L., and Hoffman, P. L. (1999). Brain-derived neurotrophic factor mediates the anti-apoptotic effect of NMDA in cerebellar granule neurons: signal transduction cascades and site of ethanol action. J. Neurosci. 19, 3277-3286.
9. Blaabjerg, M., and Zimmer, J. (2007). The dentate mossy fibers: structural organization, development and plasticity. Prog. Brain Res. 163, 85-107. doi: 10.1016/S0079-6123(07)63005-2
10. Brittain, J. M., Chen, L., Wilson, S. M., Brustovetsky, T., Gao, X., Ashpole, N. M., et al. (2011b). Neuroprotection against traumatic brain injury by a peptide derived from the collapsin response mediator protein 2 (CRMP2). J. Biol. Chem. 286, 37778-37792. doi: 10.1074/jbc.M111.255455
11. Brittain, J. M., Duarte, D. B., Wilson, S. M., Zhu, W., Ballard, C., Johnson, P. L., et al. (2011a). Suppression of inflammatory and neuropathic pain by uncoupling CRMP-2 from the presynaptic Ca(2+) channel complex. Nat. Med. 17, 822-829. doi: 10.1038/nm.2345
12. Brittain, J. M., Pan, R., You, H., Brustovetsky, T., Brustovetsky, N., Zamponi, G. W., et al. (2012a). Disruption of NMDAR-CRMP-2 signaling protects against focal cerebral ischemic damage in the rat middle cerebral artery occlusion model. Channels (Austin) 6, 52-59. doi: 10.4161/chan.18919
13. Brittain, J. M., Piekarz, A. D., Wang, Y., Kondo, T., Cummins, T. R., and Khanna, R. (2009). An atypical role for collapsin response mediator protein 2 (CRMP-2) in neurotransmitter release via interaction with presynaptic voltage-gated calcium channels. J. Biol. Chem. 284, 31375-31390. doi: 10.1074/jbc.M109.009951
14. Brittain, J. M., Wang, Y., Eruvwetere, O., and Khanna, R. (2012b). Cdk5-mediated phosphorylation of CRMP-2 enhances its interaction with CaV2.2. FEBS Lett. 586, 3813-3818. doi: 10.1016/j.febslet.2012.09.022
15. Brown, M., Jacobs, T., Eickholt, B., Ferrari, G., Teo, M., Monfries, C., et al. (2004). Alpha2-chimaerin, cyclin-dependent Kinase 5/p35, and its target collapsin response mediator protein-2 are essential components in semaphorin 3A-induced growth-cone collapse. J. Neurosci. 24, 8994-9004. doi: 10.1523/JNEUROSCI.3184-04.2004
16. Cavazos, J. E., Golarai, G., and Sutula, T. P. (1991). Mossy fiber synaptic reorganization induced by kindling: time course of development, progression, and permanence. J. Neurosci. 11, 2795-2803.
17. CDC, CfDCaP. (2012). "Epilepsy in adults and access to care-United States, 2010, " in MMWR, Vol. 61 (Washington, DC), 909-913.
18. Chae, Y. C., Lee, S., Heo, K., Ha, S. H., Jung, Y., Kim, J. H., et al. (2009). Collapsin response mediator protein-2 regulates neurite formation by modulating tubulin GTPase activity. Cell. Signal. 21, 1818-1826. doi: 10.1016/j.cellsig.2009.07.017
19. Chen, Y., Stevens, B., Chang, J., Milbrandt, J., Barres, B. A., and Hell, J. W. (2008). NS21: re-defined and modified supplement B27 for neuronal cultures. J. Neurosci. Methods 171, 239-247. doi: 10.1016/j.jneumeth.2008.03.013
20. Cole, A. R., Causeret, F., Yadirgi, G., Hastie, C. J., McLauchlan, H., McManus, E. J., et al. (2006). Distinct priming kinases contribute to differential regulation of collapsin response mediator proteins by glycogen synthase kinase-3in vivo. J. Biol. Chem. 281, 16591-16598. doi: 10.1074/jbc.M513344200
21. Cole, A. R., Knebel, A., Morrice, N. A., Robertson, L. A., Irving, A. J., Connolly, C. N., et al. (2004). GSK-3 phosphorylation of the Alzheimer epitope within collapsin response mediator proteins regulates axon elongation in primary neurons. J. Biol. Chem. 279, 50176-50180. doi: 10.1074/jbc.C400412200
22. Cross, D. A., Alessi, D. R., Cohen, P., Andjelkovich, M., and Hemmings, B. A. (1995). Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378, 785-789. doi: 10.1038/378785a0
23. Dash, P. K., Johnson, D., Clark, J., Orsi, S. A., Zhang, M., Zhao, J., et al. (2011). Involvement of the glycogen synthase kinase-3 signaling pathway in TBI pathology and neurocognitive outcome. PLoS ONE 6:e24648. doi: 10.1371/journal.pone.0024648
24. de Lanerolle, N. C., Kim, J. H., Williamson, A., Spencer, S. S., Zaveri, H. P., Eid, T., et al. (2003). A retrospective analysis of hippocampal pathology in human temporal lobe epilepsy: evidence for distinctive patient subcategories. Epilepsia 44, 677-687. doi: 10.1046/j.1528-1157.2003.32701.x
25. DePaoli-Roach, A. A. (1984). Synergistic phosphorylation and activation of ATP-Mg-dependent phosphoprotein phosphatase by F A/GSK-3 and casein kinase II (PC0.7). J. Biol. Chem. 259, 12144-12152.
26. Dustrude, E. T., Wilson, S. M., Ju, W., Xiao, Y., and Khanna, R. (2013). CRMP2 protein SUMOylation modulates NaV1.7 channel trafficking. J. Biol. Chem. 288, 24316-24331. doi: 10.1074/jbc.M113.474924
27. Endo, H., Nito, C., Kamada, H., Nishi, T., and Chan, P. H. (2006). Activation of the Akt//GSK3[beta] signaling pathway mediates survival of vulnerable hippocampal neurons after transient global cerebral ischemia in rats. J. Cereb. Blood Flow Metab. 26, 1479-1489. doi: 10.1038/sj.jcbfm.9600303
28. England, M. J., Liverman, C. T., Schultz, A. M., and Strawbridge, L. M. (2012). Epilepsy across the spectrum: promoting health and understanding. A summary of the institute of medicine report. Epilepsy Behav. 25, 266-276. doi: 10.1016/j.yebeh.2012.06.016
29. Errington, A. C., Stohr, T., Heers, C., and Lees, G. (2008). The investigational anticonvulsant lacosamide selectively enhances slow inactivation of voltage-gated sodium channels. Mol. Pharmacol. 73, 157-169. doi: 10.1124/mol.107.039867
30. Fiol, C. J., Haseman, J. H., Wang, Y. H., Roach, P. J., Roeske, R. W., Kowalczuk, M., et al. (1988). Phosphoserine as a recognition determinant for glycogen synthase kinase-3: phosphorylation of a synthetic peptide based on the G-component of protein phosphatase-1. Arch. Biochem. Biophys. 267, 797-802. doi: 10.1016/0003-9861(88)90089-6
31. Fukata, Y., Itoh, T. J., Kimura, T., Menager, C., Nishimura, T., Shiromizu, T., et al. (2002). CRMP-2 binds to tubulin heterodimers to promote microtubule assembly. Nat. Cell Biol. 4, 583-591. doi: 10.1038/ncb825
32. Ghasemi, M., and Schachter, S. C. (2011). The NMDA receptor complex as a therapeutic target in epilepsy: a review. Epilepsy Behav. 22, 617-640. doi: 10.1016/j.yebeh.2011.07.024
33. Goddard, G. V., McIntyre, D. C., and Leech, C. K. (1969). A permanent change in brain function resulting from daily electrical stimulation. Exp. Neurol. 25, 295-330. doi: 10.1016/0014-4886(69)90128-9
34. Goshima, Y., Nakamura, F., Strittmatter, P., and Strittmatter, S. M. (1995). Collapsin-induced growth cone collapse mediated by an intracellular protein related to UNC-33. Nature 376, 509-514. doi: 10.1038/376509a0
35. Goslin, K., and Banker, G. (1989). Experimental observations on the development of polarity by hippocampal neurons in culture. J. Cell Biol. 108, 1507-1516. doi: 10.1083/jcb.108.4.1507
36. Grady, M. S., Charleston, J. S., Maris, D., Witgen, B. M., and Lifshitz, J. (2003). Neuronal and glial cell number in the hippocampus after experimental traumatic brain injury: analysis by stereological estimation. J. Neurotrauma 20, 929-941. doi: 10.1089/089771503770195786
37. Hauser, W. A., and Kurland, L. T. (1975). The epidemiology of epilepsy in Rochester, Minnesota, 1935 through 1967. Epilepsia 16, 1-66. doi: 10.1111/j.1528-1157.1975.tb04721.x
38. Hirtz, D., Thurman, D. J., Gwinn-Hardy, K., Mohamed, M., Chaudhuri, A. R., and Zalutsky, R. (2007). How common are the "common" neurologic disorders? Neurology 68, 326-337. doi: 10.1212/01.wnl.0000252807.38124.a3
39. Hou, S. T., Jiang, S. X., Aylsworth, A., Ferguson, G., Slinn, J., Hu, H., et al. (2009). CaMKII phosphorylates collapsin response mediator protein 2 and modulates axonal damage during glutamate excitotoxicity. J. Neurochem. 111, 870-881. doi: 10.1111/j.1471-4159.2009.06375.x
40. Ju, W., Li, Q., Wilson, S. M., Brittain, J. M., Meroueh, L., and Khanna, R. (2013). SUMOylation alters CRMP2 regulation of calcium influx in sensory neurons. Channels 7, 153-159. doi: 10.4161/chan.24224
41. Kharatishvili, I., and Pitkanen, A. (2010). Posttraumatic epilepsy. Curr. Opin. Neurol. 23, 183-188. doi: 10.1097/WCO.0b013e32833749e4
42. Kimura, T., Watanabe, H., Iwamatsu, A., and Kaibuchi, K. (2005). Tubulin and CRMP-2 complex is transported via Kinesin-1. J. Neurochem. 93, 1371-1382. doi: 10.1111/j.1471-4159.2005.03063.x
43. Koyama, R., and Ikegaya, Y. (2004). Mossy fiber sprouting as a potential therapeutic target for epilepsy. Curr. Neurovasc. Res. 1, 3-10. doi: 10.2174/1567202043480242
44. Larner, A. J. (1995). Axonal sprouting and synaptogenesis in temporal lobe epilepsy: possible pathogenetic and therapeutic roles of neurite growth inhibitory factors. Seizure 4, 249-258. doi: 10.1016/S1059-1311(95)80001-8
45. Lee, C.-Y., Jaw, T., Tseng, H.-C., Chen, I. C., and Liou, H.-H. (2012). Lovastatin modulates glycogen synthase kinase-3β pathway and inhibits mossy fiber sprouting after pilocarpine-induced status epilepticus. PLoS ONE 7:e38789. doi: 10.1371/journal.pone.0038789
46. Lees, G., Stohr, T., and Errington, A. C. (2006). Stereoselective effects of the novel anticonvulsant lacosamide against 4-AP induced epileptiform activity in rat visual cortex in vitro. Neuropharmacology 50, 98-110. doi: 10.1016/j.neuropharm.2005.08.016
47. LeTiran, A., Stables, J. P., and Kohn, H. (2001). Functionalized amino acid anticonvulsants: synthesis and pharmacological evaluation of conformationally restricted analogues. Bioorg. Med. Chem. 9, 2693-2708. doi: 10.1016/S0968-0896(01)00204-8
48. Licko, T., Seeger, N., Zellinger, C., Russmann, V., Matagne, A., and Potschka, H. (2013). Lacosamide treatment following status epilepticus attenuates neuronal cell loss and alterations in hippocampal neurogenesis in a rat electrical status epilepticus model. Epilepsia 54, 1176-1185. doi: 10.1111/epi.12196
49. Lowenstein, D. H., Thomas, M. J., Smith, D. H., and McIntosh, T. K. (1992). Selective vulnerability of dentate hilar neurons following traumatic brain injury: a potential mechanistic link between head trauma and disorders of the hippocampus. J. Neurosci. 12, 4846-4853.
50. Manford, M., Hart, Y. M., Sander, J. W., and Shorvon, S. D. (1992a). National General Practice Study of Epilepsy (NGPSE): partial seizure patterns in a general population. Neurology 42, 1911-1917. doi: 10.1212/WNL.42.10.1911
51. Manford, M., Hart, Y. M., Sander, J. W., and Shorvon, S. D. (1992b). The national general practice study of epilepsy. the syndromic classification of the international league against epilepsy applied to epilepsy in a general population. Arch. Neurol. 49, 801-808. doi: 10.1001/archneur.1992.00530320025008
52. O'Dell, C. M., Das, A., Wallace, G. T., Ray, S. K., and Banik, N. L. (2012). Understanding the basic mechanisms underlying seizures in mesial temporal lobe epilepsy and possible therapeutic targets: a review. J. Neurosci. Res. 90, 913-924. doi: 10.1002/jnr.22829
53. Oliva, M., Berkovic, S. F., and Petrou, S. (2012). Sodium channels and the neurobiology of epilepsy. Epilepsia 53, 1849-1859. doi: 10.1111/j.1528-1167.2012.03631.x
54. Panayiotopoulos, C. P. (2005). The Epilepsies: Seizures, Syndromes and Management. Oxfordshire: Bladon Medical Publishing, an imprint of Springer Science+Business Media.
55. Park, K. D., Morieux, P., Salome, C., Cotten, S. W., Reamtong, O., Eyers, C., et al. (2009). Lacosamide isothiocyanate-based agents: novel agents to target and identify lacosamide receptors. J. Med. Chem. 52, 6897-6911. doi: 10.1021/jm9012054
56. Pitkanen, A., Immonen, R., Ndode-Ekane, X., Grohn, O., Stohr, T., and Nissinen, J. (2014). Effect of lacosamide on structural damage and functional recovery after traumatic brain injury in rats. Epilepsy Res. 108, 653-665. doi: 10.1016/j.eplepsyres.2014.02.001
57. Pitkänen, A., and Lukasiuk, K. (2009). Molecular and cellular basis of epileptogenesis in symptomatic epilepsy. Epilepsy Behav. 14(1 Suppl. 1), 16-25. doi: 10.1016/j.yebeh.2008.09.023
58. Sasaki, C., Hayashi, T., Zhang, W. R., Warita, H., Manabe, Y., Sakai, K., et al. (2001). Different expression of glycogen synthase kinase-3beta between young and old rat brains after transient middle cerebral artery occlusion. Neurol. Res. 23, 588-592. doi: 10.1179/016164101101199054
59. Shapira, M., Licht, A., Milman, A., Pick, C. G., Shohami, E., and Eldar-Finkelman, H. (2007). Role of glycogen synthase kinase-3beta in early depressive behavior induced by mild traumatic brain injury. Mol. Cell. Neurosci. 34, 571-577. doi: 10.1016/j.mcn.2006.12.006
60. Sharma, A. K., Reams, R. Y., Jordan, W. H., Miller, M. A., Thacker, H. L., and Snyder, P. W. (2007). Mesial temporal lobe epilepsy: pathogenesis, induced rodent models and lesions. Toxicol. Pathol. 35, 984-999. doi: 10.1080/01926230701748305
61. Siwek, M., Henseler, C., Broich, K., Papazoglou, A., and Weiergraber, M. (2012). Voltage-gated Ca(2+) channel mediated Ca(2+) influx in epileptogenesis. Adv. Exp. Med. Biol. 740, 1219-1247. doi: 10.1007/978-94-007-2888-2_55
62. Sutula, T. P. (2004). Mechanisms of epilepsy progression: current theories and perspectives from neuroplasticity in adulthood and development. Epilepsy Res. 60, 161-171. doi: 10.1016/j.eplepsyres.2004.07.001
63. Timm, F. (1958). Zur Histochemie der Schwermetalle Das Sulfid-Silberverfahren. Dtsch. Z. Ges. Gerichtl. Med. 46, 706-711.
64. Uchida, Y., Ohshima, T., Sasaki, Y., Suzuki, H., Yanai, S., Yamashita, N., et al. (2005). Semaphorin3A signalling is mediated via sequential Cdk5 and GSK3beta phosphorylation of CRMP2: implication of common phosphorylating mechanism underlying axon guidance and Alzheimer's disease. Genes Cells 10, 165-179. doi: 10.1111/j.1365-2443.2005.00827.x
65. Uchida, Y., Ohshima, T., Yamashita, N., Ogawara, M., Sasaki, Y., Nakamura, F., et al. (2009). Semaphorin3A signaling mediated by Fyn-dependent tyrosine phosphorylation of collapsin response mediator protein 2 at tyrosine 32. J. Biol. Chem. 284, 27393-27401. doi: 10.1074/jbc.M109.000240
66. Wang, Y., Brittain, J. M., Jarecki, B. W., Park, K. D., Wilson, S. M., Wang, B., et al. (2010). In silico docking and electrophysiological characterization of lacosamide binding sites on collapsin response mediator protein 2 (CRMP-2) identifies a pocket important in modulating sodium channel slow inactivation. J. Biol. Chem. 285, 25296-25307. doi: 10.1074/jbc.M110.128801
67. Wang, Y., and Khanna, R. (2011). Voltage-gated calcium channels are not affected by the novel anti-epileptic drug lacosamide. Transl. Neurosci. 2, 13-22. doi: 10.2478/s13380-011-0002-9
68. Wilson, S. M., Schmutzler, B. S., Brittain, J. M., Dustrude, E. T., Ripsch, M. S., Pellman, J. J., et al. (2012a). Inhibition of transmitter release and attenuation of aids therapy-induced and tibial nerve injury-related painful peripheral neuropathy by novel synthetic Ca2+ channel peptides. J. Biol. Chem. 287, 35065-35077. doi: 10.1074/jbc.M112.378695
69. Wilson, S. M., Xiong, W., Wang, Y., Ping, X., Head, J. D., Brittain, J. M., et al. (2012b). Prevention of posttraumatic axon sprouting by blocking collapsin response mediator protein 2-mediated neurite outgrowth and tubulin polymerization. Neuroscience 210, 451-466. doi: 10.1016/j.neuroscience.2012.02.038
70. Xiong, T., Tang, J., Zhao, J., Chen, H., Zhao, F., Li, J., et al. (2012). Involvement of the Akt/GSK-3β/CRMP-2 pathway in axonal injury after hypoxic-ischemic brain damage in neonatal rat. Neuroscience 216, 123-132. doi: 10.1016/j.neuroscience.2012.04.052
71. Yang, L., Afroz, S., Michelson, H. B., Goodman, J. H., Valsamis, H. A., and Ling, D. S. (2010b). Spontaneous epileptiform activity in rat neocortex after controlled cortical impact injury. J. Neurotrauma 27, 1541-1548. doi: 10.1089/neu.2009.1244
72. Yang, T., Zhou, D., and Stefan, H. (2010a). Why mesial temporal lobe epilepsy with hippocampal sclerosis is progressive: uncontrolled inflammation drives disease progression? J. Neurol. Sci. 296, 1-6. doi: 10.1016/j.jns.2010.06.002
73. Yoshimura, T., Kawano, Y., Arimura, N., Kawabata, S., Kikuchi, A., and Kaibuchi, K. (2005). GSK-3[beta] Regulates Phosphorylation of CRMP-2 and Neuronal Polarity. Cell 120, 137-149. doi: 10.1016/j.cell.2004.11.012
74. Zhang, X., Chen, Y., Ikonomovic, M. D., Nathaniel, P. D., Kochanek, P. M., Marion, D. W., et al. (2006). Increased phosphorylation of protein kinase B and related substrates after traumatic brain injury in humans and rats. J. Cereb. Blood Flow Metab. 26, 915-926. doi: 10.1038/sj.jcbfm.9600238
75. Zhao, S., Fu, J., Liu, X., Wang, T., Zhang, J., and Zhao, Y. (2012). Activation of Akt/GSK-3beta/beta-catenin signaling pathway is involved in survival of neurons after traumatic brain injury in rats. Neurol. Res. 34, 400-407. doi: 10.1179/1743132812Y.0000000025
76. Zimmer, J. (1973). Changes in the Timm sulfide silver staining pattern of the rat hippocampus and fascia dentata following early postnatal deafferentation. Brain Res. 64, 313-326. doi: 10.1016/0006-8993(73)90186-8